HIGHLIGHTS
- who: Yuanfa Feng from the Peking People`s Hospital, China have published the paper: Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer, in the Journal: (JOURNAL)
- what: The authors explored the cell heterogeneity and transcriptional alteration that induced by enzalutamide and identified a heterogeneous cluster that resists enzalutamidetreatment by using single-cell_RNA_sequencing (scRNA-seq) analysis. Differential expression analysis was carried out to explore the DEGs between C7 and other clusters.
- how: Standard pre-processing workflow including data normalization and scaling and the detection of highly variable features were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.